Vaginal epithelial cell surface glycoproteins and extracellular matrix components

The vaginal epithelial cell surface glycoproteins and extracellular matrix (ECM) components represent a complex physiological barrier essential for maintaining reproductive health and preventing infection. This target group includes membrane-associated mucins such as MUC1, MUC4, and MUC16, which form the glycocalyx, as well as ECM proteins like collagen, laminin, and fibronectin that provide structural support to the vaginal wall (Gipson, 2016; PMID: 27503611). Biologically, these molecules facilitate cell-cell adhesion, provide lubrication, and serve as a primary innate immune defense by trapping pathogens and preventing their attachment to underlying epithelial cells (Moncla et al., 2015; PMID: 26153445). In pharmacology, these components are targeted primarily for mucoadhesive drug delivery, where polymers like carbomers or chitosan interact with mucins to prolong the residence time of microbicides or hormonal treatments (Valenta, 2005; PMID: 15932681). Drugs such as Dapivirine and Tenofovir are often formulated to interact with this mucosal environment to prevent the transmission of HIV and other sexually transmitted infections (Shattock & Moore, 2003; PMID: 12754500). However, therapeutic interventions must be carefully designed to avoid disrupting the natural microbiome or causing epithelial irritation, which could paradoxically increase infection risk.

Other names

Vaginal mucosal barrierVaginal glycocalyxVaginal extracellular matrixVaginal epithelial surface moleculesVaginal mucins

Mucoadhesion via non-covalent interactions (hydrogen bonding and electrostatic forces) with mucins; physical barrier formation to prevent pathogen entry; competitive inhibition of viral binding sites on the cell surface.